INCY
Incyte Genomics IncData: 2026-10-02
Quick Stats
Oct 02, 202656.3
AI Score
HOLD1.51
Volume Ratio
Oct 27, 2026
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
INCY Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
INCY Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
INCY Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INCY Daily Out of Money Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INCY Daily In the Money Options - Sort by Max open Interest (near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INCY Most Active Options by Volume(near term)
3rd October 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
INCY Technical Chart Pro Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
INCY Stock Summary
Last updated Oct 02, 2026
INCY is currently trading at $115.3, positioned above its 200-day moving average of $106.86, indicating a long-term uptrend. The stock has a 52-week range of $82.815 to $132.6.
Technical Analysis: The 50-day moving average stands at $123.63, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 33.662, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.263, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates INCY at 56.3/100 with a HOLD recommendation.
INCY (Incyte Genomics Inc) Indicators
Last updated Oct 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 33.662 |
| CMF (20) | -0.263 |
| ROC (10) | -7.988 |
| ADX (14) | 15.704 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -1.198 |
| AROONOSC (14) | -71.429 |
| WILLAMS %R (14) | -94.841 |
| MFI (14) | 24.494 |
INCY Candlestick Patterns
Validated patterns fired in the last 10 sessions. Hit rate = how often price moved in the signal's direction within 5 trading days (backtest: 2.7M signals, 3,500 liquid stocks, Feb 2025–Sep 2026). Baseline: a random stock closes higher 5 days later 53% of the time. Click a row to see the candle on the chart.
| Date | Pattern | Signal | 5-Day Hit Rate | Edge vs Baseline | Sample |
|---|---|---|---|---|---|
| Sep 22 | Gap Three Methods (bearish) (contrarian — textbook says the opposite) | Bullish | 56.1% | +3.0 pts | 4558 |
These are statistical tilts, not standalone trade setups. Only patterns with a measured edge are shown — roughly 50 of 60 textbook patterns showed no edge and are hidden.
Incyte Genomics Inc is above the 200 Day SMA but below the 50 Day SMA — long-term uptrend intact but under near-term pressure (Mixed).
INCY Moving Averages Analysis
Incyte Genomics Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Oct 02, 2026
INCY (Incyte Genomics Inc) Simple Moving Averages
Moving Averages are last updated Oct 02, 2026
| Days | MA |
|---|---|
| 10 | 122.64 |
| 20 | 123.49 |
| 30 | 124.69 |
| 50 | 123.63 |
| 100 | 114.84 |
| 200 | 106.86 |
INCY Fundamental Analysis
| P/E (Forward) | 14.7059 |
| P/E (Trailing) | 15.4538 |
| Market Cap ($) | 23.7 billion |
| Earnings/Share ($) | 7.58 |
| Net Profit Margin (%) | 0.2771 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 3.4241 |
| EPS Estimate Next Year ($) | 8.8144 |
| WallStreet Target Price ($) | 128.48 |
| Most Recent Quarter |
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.